Norman Fields Gottscho Capital Management LLC Sells 2,025 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Norman Fields Gottscho Capital Management LLC lessened its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 7.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 23,975 shares of the company’s stock after selling 2,025 shares during the quarter. Norman Fields Gottscho Capital Management LLC’s holdings in Roche were worth $836,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Brooklyn Investment Group acquired a new stake in Roche in the third quarter valued at $40,000. AlphaMark Advisors LLC acquired a new position in shares of Roche in the third quarter worth approximately $149,000. IHT Wealth Management LLC bought a new stake in Roche in the third quarter valued at approximately $236,000. Verity Asset Management Inc. bought a new stake in Roche in the third quarter valued at approximately $253,000. Finally, Canopy Partners LLC raised its holdings in Roche by 4.6% during the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after purchasing an additional 344 shares during the last quarter.

Roche Stock Up 1.0 %

Shares of RHHBY stock opened at $35.52 on Tuesday. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $42.43. The firm has a 50 day moving average of $36.18 and a 200-day moving average of $37.97.

Wall Street Analysts Forecast Growth

RHHBY has been the topic of a number of analyst reports. Bank of America raised shares of Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft lowered Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.